MS in Pharmacology and MBA Dual Degree Program
The MS/MBA Program has a proven track record of our graduates getting jobs predominantly in pharmaceutical companies. See the MS/MBA outcomes tab below for a list of positions and the companies where our alumni arecurrently working. A few graduates decide to continue their education in medical or dental schools.
The Department of Molecular Pharmacology & Neuroscience and the Loyola University Chicago Quinlan School of Business offer full time 2.5-year and part-time 4-year dual degree programs. These programs lead to a Master of Science (MS) in Pharmacology degree and a Master of Business Administration (MBA) degree. This program is especially designed for individuals who are planning a career in the pharmaceutical, biotechnology, or other health-related industries. The ability of our graduates to understand both the science and business aspects of developing and marketing a new product or therapy gives them a competitive advantage in obtaining a position in industry and advancing their careers. This dual degree program also allows students to earn the two degrees in a shorter period of time than completing each one separately.
Internship Opportunities for Future Graduate Students
Students who have a GPA in the MS in Pharmacology of 3.5 or higher and are interested in having an internship in a pharmacetuical company will be recommended for internship slots with major Biotech/Pharm companies. We have an excellent track record of placing students and most such internships lead to positions (see our MS/MBA Outcomes).
Testimonials from graduates of our MS/MBA program:
"Having an MS/MBA degree certainly opened doors to me that would have been closed with just a traditional MBA"
"Adding a Masters in Pharmacology to the mix really improves your prospects in the job market because it shows you have a diversified skill set that sets you apart from other applicants."
"I have an edge with the additional business degree."
"I basically cut off 6 years to get where I am now."
Application deadline is June 15, 2025
The MS/MBA Program has a proven track record of our graduates getting jobs predominantly in pharmaceutical companies. See the MS/MBA outcomes tab below for a list of positions and the companies where our alumni arecurrently working. A few graduates decide to continue their education in medical or dental schools.
The Department of Molecular Pharmacology & Neuroscience and the Loyola University Chicago Quinlan School of Business offer full time 2.5-year and part-time 4-year dual degree programs. These programs lead to a Master of Science (MS) in Pharmacology degree and a Master of Business Administration (MBA) degree. This program is especially designed for individuals who are planning a career in the pharmaceutical, biotechnology, or other health-related industries. The ability of our graduates to understand both the science and business aspects of developing and marketing a new product or therapy gives them a competitive advantage in obtaining a position in industry and advancing their careers. This dual degree program also allows students to earn the two degrees in a shorter period of time than completing each one separately.
Internship Opportunities for Future Graduate Students
Students who have a GPA in the MS in Pharmacology of 3.5 or higher and are interested in having an internship in a pharmacetuical company will be recommended for internship slots with major Biotech/Pharm companies. We have an excellent track record of placing students and most such internships lead to positions (see our MS/MBA Outcomes).
Testimonials from graduates of our MS/MBA program:
"Having an MS/MBA degree certainly opened doors to me that would have been closed with just a traditional MBA"
"Adding a Masters in Pharmacology to the mix really improves your prospects in the job market because it shows you have a diversified skill set that sets you apart from other applicants."
"I have an edge with the additional business degree."
"I basically cut off 6 years to get where I am now."
Application deadline is June 15, 2025